We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$8.76B
AUM Growth
+$460M
Cap. Flow
+$106M
Cap. Flow %
1.21%
Top 10 Hldgs %
10.77%
Holding
1,514
New
104
Increased
381
Reduced
276
Closed
126

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$70.5M
2
T icon
AT&T
T
+$52.8M
3
FCX icon
Freeport-McMoran
FCX
+$47M
4
CME icon
CME Group
CME
+$46.3M
5
MRO
Marathon Oil Corporation
MRO
+$41.4M

Sector Composition

Rank Sector Weight
1 Financials 23.37%
2 Industrials 14.93%
3 Technology 13.85%
4 Consumer Discretionary 11.09%
5 Healthcare 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CETX icon
1326
Cemtrex
CETX
$4.32M
0
PRMW
1327
DELISTED
Primo Water Corporation
PRMW
$119K ﹤0.01%
10,000
CATX icon
1328
Perspective Therapeutics
CATX
$327M
$118K ﹤0.01%
22,850
AMS icon
1329
American Shared Hospital Services
AMS
$10.1M
$117K ﹤0.01%
+41,200
New +$137K
UTSI icon
1330
UTStarcom
UTSI
$22M
$117K ﹤0.01%
12,150
CFBK icon
1331
CF Bankshares
CFBK
$239M
$116K ﹤0.01%
8,691
TRT
1332
Trio-Tech International
TRT
$92M
$115K ﹤0.01%
44,000
+20,000
+83% +$46.2K
CRMD icon
1333
CorMedix
CRMD
$564M
$113K ﹤0.01%
43,540
-1,400
-3% -$2.9K
CRD.A icon
1334
Crawford & Co Class A
CRD.A
$542M
$111K ﹤0.01%
11,600
EVRI
1335
DELISTED
Everi Holdings
EVRI
$109K ﹤0.01%
14,350
-50,000
-78% -$376K
KIN
1336
DELISTED
Kindred Biosciences, Inc.
KIN
$109K ﹤0.01%
13,900
APVO icon
1337
Aptevo Therapeutics
APVO
$4.96M
0
OREX
1338
DELISTED
Orexigen Therapeutics, Inc.
OREX
$104K ﹤0.01%
+49,100
New +$120K
CARM
1339
DELISTED
Carisma Therapeutics
CARM
$103K ﹤0.01%
3,250
BSF
1340
DELISTED
Bear State Financial, Inc.
BSF
$103K ﹤0.01%
10,000
STLY
1341
DELISTED
Stanley Furniture Co Inc
STLY
$102K ﹤0.01%
86,383
-63,000
-42% -$74.8K
ATEC icon
1342
Alphatec Holdings
ATEC
$1.48B
$101K ﹤0.01%
44,800
+25,000
+126% +$48.1K
ATNM icon
1343
Actinium Pharmaceuticals
ATNM
$26.3M
$99K ﹤0.01%
5,743
-5,000
-47% -$110K
BIOA
1344
DELISTED
BioAmber Inc.
BIOA
$99K ﹤0.01%
201,700
DZSI
1345
DELISTED
DZS Inc. Common Stock
DZSI
$98K ﹤0.01%
14,420
MEET
1346
DELISTED
The Meet Group, Inc. Common Stock
MEET
$98K ﹤0.01%
26,831
DTRM
1347
DELISTED
Determine, Inc. Common Stock
DTRM
$97K ﹤0.01%
45,233
-36,500
-45% -$76.5K
FSI icon
1348
Flexible Solutions
FSI
$64.6M
$96K ﹤0.01%
55,707
SANW
1349
DELISTED
S&W Seed Co
SANW
$95K ﹤0.01%
1,579
STKS icon
1350
The ONE Group
STKS
$55.9M
$90K ﹤0.01%
53,700

Similar funds

Bridgeway Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Bridgeway Capital Management held 1,514 positions worth $8.76B, up 5.5% from $8.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management's Q3 2017 filing shows 104 new, 381 increased, 276 reduced and 126 closed positions. Its largest new stake was Ameren: 832,900 shares worth $48.2M. The largest sale was Andeavor, an estimated $70.5M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • Bridgeway Capital Management's largest Q3 2017 buy was Ameren: 832,900 shares worth $48.2M.
  • Bridgeway Capital Management added most to Comcast in Q3 2017, an estimated $46.5M increase.
  • Bridgeway Capital Management's biggest Q3 2017 reduction was AT&T, cutting an estimated $52.8M.
  • Bridgeway Capital Management fully exited Andeavor in Q3 2017, selling an estimated $70.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $8.76B portfolio in Q3 2017.
  • Bridgeway Capital Management opened 104 new positions and closed 126 in Q3 2017.
  • Bridgeway Capital Management's portfolio value rose 5.5% quarter-over-quarter to $8.76B.

Based on Bridgeway Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.